Purpose Human breath analysis is proposed with increasing frequency as a useful tool in clinical application. We performed this study to find the characteristic volatile organic compounds (VOCs) in the exhaled breath of patients with idiopathic pulmonary fibrosis (IPF) for discrimination from healthy subjects. Methods VOCs in the exhaled breath of 40 IPF patients and 55 healthy controls were measured using a multi-capillary column and ion mobility spectrometer. The patients were examined by pulmonary function tests, blood gas analysis, and serum biomarkers of interstitial pneumonia. Results We detected 85 VOC peaks in the exhaled breath of IPF patients and controls. IPF patients showed 5 significant VOC peaks; p-cymene, acetoin, isoprene, ethylbenzene, and an unknown compound. The VOC peak of p-cymene was significantly lower (p < 0.001), while the VOC peaks of acetoin, isoprene, ethylbenzene, and the unknown compound were significantly higher (p < 0.001 for all) compared with the peaks of controls. Comparing VOC peaks with clinical parameters, negative correlations with VC (r =−0.393, p = 0.013), %VC (r =−0.569, p < 0.001), FVC (r = −0.440, p = 0.004), %FVC (r =−0.539, p < 0.001), DLco (r =−0.394, p = 0.018), and %DLco (r =−0.413, p = 0.008) and a positive correlation with KL-6 (r = 0.432, p = 0.005) were found for p-cymene. Conclusion We found characteristic 5 VOCs in the exhaled breath of IPF patients. Among them, the VOC peaks of p-cymene were related to the clinical parameters of IPF. These VOCs may be useful biomarkers of IPF.
This is a preview of subscription content, log in to check access.
The authors thank Mr. Yusuke Yonemura (Harada Corp, Osaka, Japan) for his technical supports. A part of the work on this paper (JIBB) has been supported by Deutsche Forschungsgemeinschaft (DFG) within the Collaborative Research Center (Sonderforschungsbereich) SFB 876 “Providing Information by Resource-Constrained Analysis”, project TB1 “Resource-Constrained Analysis of Spectrometry Data”.
Compliance with Ethical Standards
Conflict of interest
The authors have declared no conflicts of interest in connection with this article.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in this study.
Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMedGoogle Scholar
Rattray NJ, Hamrang Z, Trivedi DK et al (2014) Taking your breath away: metabolomics breathes life in to personalized medicine. Trends Biotechnol 32:538–548CrossRefPubMedGoogle Scholar
Westhoff M, Litterst P, Maddula S et al (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobility Spectrum 13:131–139CrossRefGoogle Scholar
Van Berkel JJ, Dallinga JW, Möller GM et al (2010) A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med 104:557–567CrossRefPubMedGoogle Scholar
Besa V, Teschler H, Kurth I et al (2015) Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects. Int J Chron Obstruct Pulmon Dis 10:399–406PubMedPubMedCentralGoogle Scholar
Dragonieri S, Schot R, Mertens BJ et al (2007) An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 120:856–862CrossRefPubMedGoogle Scholar
Bunkowski A, Boedeker B, Bader S et al (2009) MCC/IMS signals in human breath related to sarcoidosis: results of a feasibility study using an automated peak finding procedure. J Breath Res 3:046001CrossRefPubMedGoogle Scholar
Westhoff M, Litterst P, Freitag L et al (2007) Ion mobility spectrometry in the diagnosis of sarcoidosis: Results of a feasibility study. J Physiol Pharmacol 58:739–751PubMedGoogle Scholar
Phillips M, Cataneo RN, Condos R et al (2007) Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis 87:44–52CrossRefPubMedGoogle Scholar
Phillips M, Basa-Dalay V, Blais J et al (2012) Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis 92:314–320CrossRefPubMedGoogle Scholar
Westhoff M, Litterst P, Freitag L et al (2009) Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64:744–748CrossRefPubMedGoogle Scholar
Darwiche K, Baumbach JI, Sommerwerck U et al (2011) Bronchoscopically obtained volatile biomarkers in lung cancer. Lung 189:445–452CrossRefPubMedGoogle Scholar
Kanoh S, Kobayashi H, Motoyoshi K (2005) Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases. Chest 128:2387–2392CrossRefPubMedGoogle Scholar
Buszewski B, Grzywinski D, Ligor T et al (2013) Detection of volatile organic compounds as biomarkers in breath analysis by different analytical techniques. Bioanalysis 5: 2287–2306CrossRefPubMedGoogle Scholar
Baumbach JI (2009) Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res 3:034001CrossRefPubMedGoogle Scholar
Hauschild AC, Schneider T, Pauling J et al (2012) Computational methods for metabolomic data analysis of ion mobility spectrometry data-reviewing the state of art. Metabolites 2: 733–755CrossRefPubMedPubMedCentralGoogle Scholar
Cumeras R, Figueras E, Davis CE et al (2015) Review on ion mobility spectrometry. Part 2: hyphenated methods and effects of experimental parameters. Analyst 140:1391–1410CrossRefPubMedPubMedCentralGoogle Scholar
Foster WM, Jiang L, Stetkiewicz PT et al (1996) Breath isoprene: temporal changes in respiratory output after exposure to ozone. J Appl Physiol 80:706–710PubMedGoogle Scholar
Jalali M, Zare Sakhvidi MJ, Bahrami A et al (2016) Oxidative stress biomarkers in exhaled breath of workers exposed to crystalline silica dust by SPME-GC-MS. J Res Health Sci 16:153–161PubMedGoogle Scholar
Cheresh P, Kim SJ, Tulasiram S et al (2013) Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta 1832: 1028–1040CrossRefPubMedGoogle Scholar
Chan PC, Haseman JK, Mahleri J et al (1998) Tumor induction in F344/N rats and B6C3F1 mice following inhalation exposure to ethylbenzene. Toxicol Lett 99:23–32CrossRefPubMedGoogle Scholar
Saghir SA, Zhang F, Rick DL et al (2010) In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis. Regul Toxicol Pharmacol 57:129–135CrossRefPubMedGoogle Scholar
Song G, Qin T, Liu H et al (2010) Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 67:227–231CrossRefPubMedGoogle Scholar
Xie G, Chen N, Soromou LW et al (2012) p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules 17:8159–8173CrossRefPubMedGoogle Scholar